Hims & Hers Health
HIMS
29.54
+0.07
+0.24%
Hims & Hers Health
US · HIMS
#1813 by market cap
Listed 1970
29.54
+0.07
+0.24%
Live - 5344 symbols - heartbeat 397s ago
· 2026-10-08 08:30
Pre-market
29.46
-0.27%
After-hours
29.59
+0.18%
Overnight
29.43
-0.37%
- Market cap
- 6.89B
- P/E (TTM)i
- -46.16
- P/Bi
- 21.27
- EPSi
- 0.51
- Div yieldi
- 0.00%
- 52W posi
- 31%
Reader sentiment
Are you bullish or bearish on HIMS?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.SEC · 2026/6/18
-
Rating change
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $30Market Newswire · 2026/7/30
-
Rating change
A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $32 to $42Market Newswire · 2026/8/12
-
Rating change
J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?TipRanks · 2026/9/12
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.SEC · 2026/3/18
-
BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32Market Newswire · 2026/9/25
-
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32Market Newswire · 2026/9/11
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Director Cosgrove Delos M.SEC · 2026/6/16
-
Rating change
CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/7/24
-
KeyBanc Maintains Hims & Hers Health(HIMS.US) With Hold RatingMarket Newswire · 2026/9/2
-
Rating change
Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $33Market Newswire · 2026/8/13
-
Rating change
Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $35Market Newswire · 2026/7/30
-
Rating change
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold RatingMarket Newswire · 2026/8/10
-
J.P. Morgan Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32Market Newswire · 2026/9/11
-
Company notice
8-K: Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports First Quarter 2026 Financial ResultsSEC · 2026/5/12
-
Rating change
Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32Market Newswire · 2026/8/25
-
Company notice
Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.SEC · 2026/6/16
-
Rating change
BTIG Maintains Hims & Hers Health(HIMS.US) With Hold RatingMarket Newswire · 2026/7/30
-
Rating change
Barclays Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Cuts Target Price to $35Market Newswire · 2026/8/21
-
Jefferies Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $31Market Newswire · 2026/9/3
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:30:10 · For reference only, not investment advice and not tailored to your situation.